Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emapalumab dose-finding and safety study to prevent graft failure after allogeneic hematopoietic stem cell transplantation
MOH_2020-11-16_009279Phase 2Not yet recruiting
- Sponsor
- Sobi
- Start
- Oct 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of emapalumab in Bone marrow transplant failure, sponsored by Sobi. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
emapalumab
03
Conditions
Bone marrow transplant failure
Beyond the preview
Go deeper on MOH_2020-11-16_009279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-11-16_009279.